Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...
Pfizer shares have gained ground since a report over the weekend said that activist investor Starboard Value has taken a roughly $1 billion stake in the drug maker and is pushing for changes. Monitor ...
The smart money seems to be calling a bottom for the healthcare sector. That could mean it’s time for investors to start taking another look at the industry’s more beleaguered stocks. Since the start ...
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...
However, Pfizer's payout ratio of 436% raises significant concerns about sustainability. Is Pfizer's high dividend worth the risk? Let's dig deeper to find out. Pfizer is a global ...
The Wall Street Journal earlier reported news of Starboard's stake. A Pfizer spokesperson declined to comment on "speculation and rumor." — CNBC's Angelica Peebles contributed to this report.
Pfizer slashed its production targets for its COVID-19 vaccine because of a lack of raw materials for its supply chain, according to press reports. The big pharma has said in recent weeks that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback